Lung Cancer

EDU 31 - (INTERACTIVE) Challenging Cases in Lung Cancer: Oligometastatic Disease

Chemotherapeutic Management of Oligometastatic NSCLC

Tuesday, October 23
5:05 PM - 5:25 PM
Location: Room 303

Martin Edelman, MD

Fox Chase Cancer Center

Disclosure:
Employment
University of Maryland: Professor of Medicine: Employee

Compensation
Astra Zeneca: DSMB; Bristol Myers Squibb: Research Grants

Ownership
Andarix: Stock Options; Biomarker Strategies: Stock Options

Leadership
Alliance for Clinical Trials in Oncology: Board of Directors; ASCO: Chair, Education Committee (Lung Cancer); NRG: Co-chair, Lung Committee

Presentation(s):

Send Email for Martin Edelman


Assets

Chemotherapeutic Management of Oligometastatic NSCLC



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Chemotherapeutic Management of Oligometastatic NSCLC